INTRODUCTION
Enzymes of the ergosterol biosynthetic pathway have attracted a great deal of attention in recent years, because inhibitors which interfere with their function have been increasingly successful as agricultural fungicides and as antimvcotic drugs (Baldwin, 1989 ; Marriott, 1990) . However, virtually all the commercially important antifungal agents affecting sterol biosynthesis act by inhibiting enzyrries that function late in the ergosterol biosynthetic pathnTay (Kelly e t al., 1990) , that is, the enzymic steps responsible for the conversion of lanosterol to ergosterol. Established targets for antifungal ergosterol biosynthesis inhibitors include C-14 sterol demethylation, As -+ A' sterol isomerization and A1' sterol reduction (Koller, 1992) . Squalene epoxidation, which occurs at an earlier stage In sterol biosynthesis, has also been identified as a potential target for antimycotic drugs (Stutz, 1990 The EMBL accession number for the sequence reported in this paper is
230085.
to squalene expoxidation and cyclization have become available for the control of fungal diseases, in either medical or crop protection applications. This is despite an extensive pharmacological interest in the development of therapeutic drugs, directed towards these enzymes, for lowering blood cholesterol levels (Endo, 1985) .
3-Hydroxy-3-methylglutaryl-CoA (HMG-Co A) reductase (EC 1.1.1.34) is an enzyme that functions early in sterol biosynthesis. It catalyses the conversion of (4-3-hydroxy-3-methylglutaryl-coenzyme A to (R)-mevalonate. Mevalonate formed by this reaction provides C, units, used not only in sterol formation, but also for the synthesis of dolichols, ubiquinone, isopentyladenine, haem A and a diverse array of other isoprenoid metabolites (Panini e t al., 1985; . Isoprene units derived from mevalonate are also required for post-translational modification of some signalling proteins (Sinensky & Lutz, 1992) . In higher eukaryotes, HMG-CoA reductase is considered to be the key regulatory enzyme of the sterol biosynthesis pathway (Preiss, 1985) . It is subject to a number of complex metabolic regulatory mechanisms including translational and transcriptional control (Osborne, On: Mon, 21 Jan 2019 00:04:29 R. C R O X E N a n d O T H E R S enzyme activity by degradation and phosphorylation ( ( 3 1 et al., 1985 ; Clarke & Hardie, 1990 ; Gillespie & Harclie, 1992; Sat0 e t al., 1993) . The central role played by this enzyme in regulating sterol biosynthesis, and the importance of normal sterol production for growth, makes HMG-CoA reductase an attractive target for the development of new antifungal agents. This view is supported by the fact that yeast (Saccharomyes cerevisiae) mutants devoid of HMG-CoA reductase activity are unable to grow (Basson et al., 1986) . Furthermore, a number of antibiotics have been identified as powerful specific competitive inhibitors of HMG-CoA reductase (Endo, 1985) and at least two of these, compactin and lovastatin, are effective inhibitors of growth in yeasts (Ikeura ef al., 1988) .
In eukaryotes, HMG-CoA reductase is an integral mernbrane glycoprotein of the endoplasmic reticulum. Thr : e distinct regions can be recognized within the protein: a membrane anchor N-terminal domain that contains a number (1) (2) (3) (4) (5) (6) (7) (8) of hydrophobic regions which correspond to potential trans-membrane regions ; a C-terminal catalytic domain, which extends into the cytoplasm ar d contains the active site of the enzyme; and a linker region which separates these two domains. In yeast, two structural genes (HMGI and HMG2) are known to code for HMG-CoA reductase (Basson e t al., 1986) . In contrast, only a single gene has been found in mammalian genomes (Reynolds et al., 1984) , whereas at least three genets, encoding different HMG-CoA reductase isozymes, have been postulated in plants (Bach, 1987) . The amino acid sequences of HMG-CoA reductases from differer t organisms are highly conserved within the C-terminal catalytic domain. In contrast, the N-terminal sequences, in terms of both length and amino acid composition, are diverse (Basson e t al., 1988) . Nevertheless, despite this lack of homology within the N-terminal region, HMGCoA reductases from a range of organisms appear to be functionally conserved. For example, HMG-CoA reductases from human, hamster and Arabidopsis thaliam can complement yeast mutants (hmg7, hmg2) lacking HMG-CoA reductase activity (Basson e t al., 1988; Learned & Fink, 1989) .
The N-terminal membrane-bound domain, although noinecessary for catalytic activity, is required for sterolregulated degradation of the protein (Roitelman e t al. 1992) and for membrane proliferation (J ingami e t al.. 1987) . HMG-CoA reductase therefore does not need to be associated with a membrane to be catalytically active. Indeed, the HMG-CoA reductase produced by Pseudomoms mevalonii, an organism that utilizes mevalonate as a carbon source, lacks a membrane anchor domain (Beach & Rodwell, 1989) and proteolytically-cleaved soluble C-terminal fragments of the enzyme from eukaryote sources retain catalytic activity in vivo (Edwards & Fogelman, 1985) . Furthermore, active forms of the catalytic domain of HMG-CoA reductase from hamster and radish (Rhaphmzls sativzls) have been expressed in Escherichia coli (Darnay & Rodwell, 1993; Ferrer e t al., 1990; Frimpong e t al., 1993) . Heterologous expression of HMG-CoA reductase activity in this way, in conjunction with site-directed mutagenesis, has already allowed detailed investigations of catalytically important amino acid residues (Darnay et al., 1992; Darnay & Rodwell, 1993; Wang et al., 1990) .
In order to pursue a rational biochemical approach to fungicide design, high yields of pure target enzyme are required to elucidate structure-function relationships, using structural and kinetic data. Recombinant DNA technology offers an attractive route for achieving this goal. In this paper, we report the isolation o f an HMGCoA reductase gene from the basidiomycete fungal pathogen Ustilago maydis, and show that a catalytically active, truncated C-terminal fragment of the protein is expressed in a functional form in E. coli. In addition, we demonstrate that the expressed protein is sensitive to a known inhibitor of mammalian HMG-CoA reductase. was used in the expression studies. The U. mqdis genomic library was constructed in IEMBL3 (Bailey et al., 1994 ) and the cDNA library was custom synthesized in AZAPII by Clontech Laboratories. Plasmid pUC18 was used for all subcloning and sequencing procedures and pTrcHis C (Invitrogen Corporation) was used for the expression studies, following the manufacturer's instructions. DNA procedures. Genomic DNA was extracted from exponentially growing cells as described by Keon e t al. (1991) . PCR amplification was done using a GeneAmp PCR kit (Perkin Elmer). The reactions were cycled 30 times through 94 "C for 2 min, 58 O C for 1 min and 72 O C for 2 min. At the end of the amplification period the products were analysed by electrophoresis through a 1 % (w/v) SeaPlaque GTG (FMC BioProducts) agarose gel. Plaque and Southern hybridization, restriction enzyme digestion, ligation and bacterial transformation, and plasmid and bacteriophage A DNA isolation were essentially as described by Sambrook e t al. (1989) For extrnction of HMG-CoA reductase activity, IPTG-induced bacterial cells from a 50 ml culture were pelleted by centrifugation at 8OOOg for l min then resuspended in 5 ml 20 mM sodium phosphate buffer, pH 7.8, containing 10 pRil p-
METHODS

Strains
Tween 20,lO pM phenylmethylsulphon\.l fluoride and 0.1 mg lysozyme ml-'. Cells were subjected t o three cycles of freezing in liquid nitrogen and thawing at 37 O C . Between each cycle the cells were sonicated for 20 s a t 0 "C. The extract was then centrifuged at 100000 g for 30 min tc) remove cell debris. HMG-CoA reductase activity was determined spectrophotometrically by following the oxidation of NADPH (Frimpong e t al., 1993) . The reaction mixture was maintained at 37 "C and contained 200 pmol sodium phosphate buffer, pH 7.5, 10 pmol B-mercaptoethanol and 0.14 pmol NADPH In a total volume of 1 ml. The reaction was initiated by the addition of 10 pl 0.3 mM HMG-CoA. In some experiments the inhibitory action of compound WL165748 was tested. This compound ( Fig. 1 ) is a substituted dihydroxy-alklyl-indole derivatil e described in a patent (WO 84/02131) by the pharmaceutical company Sandoz as an inhibitor of mammalian HMG-L),\ reductase.
RESULTS
Amplification of an internal DNA fragment of a U. maydis HMG-CoA reductase gene
Two sets of 20-mer oligonucleotides (5'GGA GCT TGT/C TGT G A G / A AAT GT3' and 3'CTG TTC TTT GGT/ A CGA/G CGG/A TA5') were synthesized, using the standard eukaryotic nuclear gene codon assignments, that Corresponded to two conserved regions within HMG-(:oA reductase proteins derived from other organisms. The amino acid sequences encoded by these regions were Gly-Ala-Cys-Cys-Glu-Asn-Val and AspLys-Lys-Pro-Ala-Ala-Ile, respectively, and were located approximately 170 residues apart within the catalytic domain of the protein. 
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ATAGACGATGTTCTGAGGAGCAGCTCTTGAGTAGCCGGAGCTTTTGCCCTGMGCCGAG 3728 (Fig. 2) . There was still the possibility, however, that clones p31B and p41R originated from two different structural genes encoding HMG-CoA reductase.
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Isolation and sequence of the U. rnaydis HMG-CoA reductase gene
In order to isolate a D N A fragment containing a fulllength U. mqdis HMG-CoA reductase gene, the amplified PCR product was used to screen a U. mgydis AEMBL3 genomic library (approx. 40 000 clones) by plaque hybridization. Three positive clones (A3L4, 24L3 and 16L3) were identified, after hybridization at a high stringency. Digestion of D N A isolated from the three genomic 3, clones, with the restriction endonucleases Hind111 and SalI, and Southern hybridization analysis using the cDNA clones p31B and p41B as probes, identified common D N A fragments in clones 3,3L4, i4L3 and A6L3 which hybridized to both cDNA clones (data not shown). A 6.2 kb Hind111 fragment and a 6.0 kb SaA fragment, derived from 113L4, were chosen for further restriction enzyme analysis and subcloned into pUCl8 to form pUMHMGl A and pUMHMGl B, respectively (Fig.  3) . The relevant regions of the D N A inserts in these plasmids were then sequenced on both strands, by extension of specific oligonucleotides as illustrated in Fig.  3 . The nucleotide and deduced amino acid sequence of the gene are shown in Fig. 4 . The sequence starts 272 bp upstream of an initiation codon (ATG) and continues However, none of these sites could be differentiated on the basis of the nucleotide sequences surrounding initiation codons optimal for translation initiation in fungi (Ballance, 1991 ; Gurr et al., 1987; Unkles, 1992) . Neither did the location of a putative CAAT motif, at positions -240 to -236, allow discrimination between these initiation sites. proteins revealed 62-3 Yo similarity (45-4 O/O identity) and 55 YO similarity (36.7 % identity) respectively. Several stretches of conserved amino acids, also present in HMGCoA reductases from other unrelated organisms, were identified within the C-terminus catalytic domain (Fig. 5) . The hydropathy plot of the U. mqdis protein revealed eight peaks of hydrophobicity within the N-terminus domain (Fig. 6) . A similar number of hydrophobic regions have been identified in the S. cerevisiae HMG1 and HMG2 proteins, and seven of these have been recognized as membrane-spanning domains (Sengstag e t al., 1990) .
Southern analysis of Salt-, PstI-and HindIII-digested U. mqdis genomic DNA, using the amplified PCR product as a probe, resulted in hybridization patterns which were consistent with there being two related HRIG-CoA reductase genes in the U. mqdis genome (Fig. 7) . Both a 6.2 kb Hind111 fragment) in each digest corresponded tc the genomic clones recovered in this study. 
Expression of a C-terminal-truncated
DISCUSSION
As reported for S. cerevzszae (Basson e t al., 1986) (Wang e t al., 1990; Frimpong & Rodwell, 1994) . Of particular interest, with respect to the regulation of HMG-CoA reductase activity, is the serine residue at position 1099. This residue is located close to the catalytically important histidine residue. In eukaryotic HMG-CoA reductase, the serine residue at this position is known to be phosphorylated by an AMP-activated protein kinase, resulting in a loss of catalytic activity (Clarke & Hardie, 1990; Gillespie & Hardie, 1992; Sat0 etal., 1993) . This suggests that the low activity of phosphorylated HMG-CoA reductase might be due to ionic and/or steric hindrance at the active site of the enzyme (Darnay & Rodwell, 1993 et al., 1990) . In contrast, eight membrane-spanning domains have been implicated in higher eukaryote HMGCoA reductases (Roitelman e t al., 1992; . The membrane-spanning region, besides anchoring the protein to the endoplasmic reticulum, also serves A number of other functions. For example, in marnm,ilian cells, the membrane-bound portion of the protein is required for sterol-regulated proteolytic degradation of the enzyme (Gil et al., 1985) . The N-terminal region o f the protein is also important, in both 5'. cerevisiae and mammalian cells, for triggering increased membrane synthesis (Anderson et al., 1983; K'right e t al., 1988) . Structural similarities between the membrane-associated domain of HMG-CoA reductases and other eukaryotic transmcmbrane proteins that interact with heterotrimeric GTP-binding proteins have been noted (Sengstag e t al., 1990), .ind this similarity could imply that HMG-CoA reductase has a role in information transfer within the cell.
The hydrophobic N-terminal domain of HMG-CoA reductases is not necessary for the catalytic activity of the enzyme. Indeed, soluble preparations of the enzyme from tissues often contain a proteolytically-derived fragment of the natii'e protein (Edwards & Fogelman, 1985) and this propert!. of the enzyme has been exploited to gain high levels of expression of active HMG-CoA reductases in heterologous systems (Darnay & Rodwell, 1993; Ferrer et al., 1990; Frimpong et al., 1993) . A C-terminal fragment of the C'. mqdis HMG-CoA reductase was similarly catalytically active when expressed in E. coli in the present study. The K , value calculated for this recombinant protein was similar to the value obtained for HMG-CoA isolated from rat liver ( K , = 9.1 pM; Endo, 1985) . In addition, the truncated form of the protein was shown to be sensitive to an inhibitor of mammalian HMG-CoA reductases.
Expression of a catalytically active form of the U. mqdis HMG-Co14 reductase in E . coli now provides a reliable source of active enzyme in quantities necessary for more detailed kinetic and inhibitor studies. In addition, the availability of a regular supply of recombinant enzyme, in conjunction with a simple spectrophotometric assay, should enable automated procedures to be developed for routint it1 vitro screening of potential inhibitors of fungal HMG-COX reductases.
We would like to thank J . Rine 
